NewcelX Share Price
NASDAQ: NCEL | OthersNewcelX Stock Performance
NewcelX Share Price Chart
NewcelX Annual Profit & Loss
All figures in USD
NewcelX Balance Sheet
All figures in USD Million
NewcelX Cash Flow
All figures in USD Million
About NewcelX
NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.
NewcelX Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $2.52 | $2.75 | +6.40% |
Oct 2026 | $2.84 | $2.58 | -14.00% |
Sep 2026 | $3.35 | $3.00 | -8.95% |
Aug 2026 | $3.29 | $3.29 | -4.35% |
Jul 2026 | $3.95 | $3.44 | -5.62% |
Jun 2026 | $3.21 | $3.65 | +9.77% |
May 2026 | $3.69 | $3.33 | -23.30% |
Apr 2026 | $2.37 | $4.33 | +98.85% |
Mar 2026 | $2.82 | $2.18 | -24.31% |
Feb 2026 | $2.60 | $2.88 | +10.98% |
Jan 2026 | $2.36 | $2.60 | +27.90% |
Dec 2025 | $3.96 | $2.03 | -48.63% |